European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies

mAbs - United States
doi 10.4161/mabs.1.5.9630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

European Medicines Agency Policies for Clinical Trials Leave Women Unprotected

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2006English

Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency

Frontiers in Plant Science
Plant Science
2020English

Pcn22 - Marketing Authorisation Practice of the European Medicines Agency (Ema) in Oncological Indications

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Monoclonal Antibodies

Science
MultidisciplinaryPhilosophy of ScienceHistory
1996English

Benefits and Drawbacks of Moving to Biosimilar Medicines

Prescriber
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy